Search Tag: Venous Thromboembolism
2018 13 Jun
There is concern about excessive bleeding when low-molecular-weight heparins (LMWHs) are used for venous thromboembolism (VTE) prophylaxis in renal dysfunction. To evaluate whether LMWH VTE prophylaxis was safe and effective in critically ill patients with renal dysfunction, researchers conducted a subgroup analysis of PROTECT, a randomised trial...Read more
2016 02 Jun
The first European recommendations on postoperative venous thromboembolism (VTE) are on their way, and are intended to be much more practical and clinical than the U.S. recommendations, said Prof. Charles-Marc Samama , Chair of the European Task Force on Prevention of Venous Thromboembolism in Anaesthesia and Intensive Care and Chair of the ESA...Read more
2014 17 Nov
Key Messages 1. We need to Identify high risk patients early on during their hospital admission. 2. Recognise anticoagulant prophylaxis may not be suitable for all patients therefore consider other interventions to protect against VTE. 3. Focus on sustained education of healthcare professionals to increase Venous thromboembolism...Read more
2014 01 Nov
According to a study published in JAMA, prevention of venous thromboembolism (VTE) with low-molecular-weight heparin (LMWH) dalteparin in critically ill patients was more effective and had similar or lower costs compared to unfractionated heparin (UFH). The study is to be presented at the Critical Care Canada Forum. The PROTECT trial compared the...Read more